Tivic Health Systems Secures European Patents, Boosting Global Market Presence for ClearUP™

Tivic Health Systems Strengthens International Market Position with Patent Validations

Tivic Health® Systems, Inc., a leader in the bioelectronic medicine sector, achieves a significant milestone by validating two European patents in key markets including Great Britain, Germany, and France. These patents, EP3615133 and EP3615134, enhance the company’s innovative product offerings, particularly its sinus treatment device, ClearUP™. The first patent features an "Adaptive Trigger For a Microcurrent Stimulation Device," which identifies optimal treatment locations and activates the device, thereby elevating the user experience through programmable options. This advancement reflects Tivic Health's commitment to integrating cutting-edge technology into healthcare solutions.

The second patent focuses on an "Adaptive Circuit" designed for the sinus treatment device, allowing for real-time voltage adjustments during use. This feature not only optimizes comfort but also enhances the overall performance of the device, setting it apart in a competitive market. Blake Gurfein, Chief Scientific Officer at Tivic Health, highlights that these patents fortify the company’s international patent portfolio, which now boasts 16 issued and 10 pending patents across multiple regions, including the U.S., Europe, India, and China. This patent validation is a critical step in Tivic Health’s strategy to expand its global reach and product accessibility.

Tivic Health's flagship product, ClearUP™, is an FDA-approved handheld bioelectronic device that offers a drug-free alternative for managing chronic sinus conditions. Clinically validated and endorsed by healthcare professionals, ClearUP™ is now available through various online and commercial outlets. The device is designed to stimulate the trigeminal, sympathetic, and vagus nerve structures, presenting a low-risk therapeutic option for patients. With these recent developments, Tivic Health is poised to strengthen its presence in the bioelectronic medicine market, catering to a growing consumer demand for effective, non-invasive treatment methods.

In addition to these patent validations, Tivic Health's advancements in bioelectronic technology underscore the company's ongoing commitment to innovation in healthcare. As the bioelectronic medicine market expands, Tivic Health is well-positioned to lead with its unique offerings, which provide valuable alternatives to traditional treatment methods. The company's focus on creating safe and effective solutions is aligned with current healthcare trends prioritizing patient-centered approaches and drug-free therapies. For more information about Tivic Health and its innovative products, visit http://tivichealth.com.